Disease-modifying therapy prescription patterns in people with multiple sclerosis by age

BACKGROUND: Disease-modifying therapies (DMTs) for multiple sclerosis (MS) are approved for their ability to reduce disease activity, namely clinical relapses and signal changes on magnetic resonance imaging (MRI). Disease activity appears age dependent. Thus, the greatest benefit would be expected...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Neurol Disord
Egile Nagusiak: Zhang, Yinan, Salter, Amber, Jin, Shan, Culpepper, William J., Cutter, Gary R., Wallin, Mitchell, Stuve, Olaf
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2021
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020738/
https://ncbi.nlm.nih.gov/pubmed/33868459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562864211006499
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak